⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
GANX News
Gain Therapeutics, Inc. Common Stock
Form 8-K
sec.gov
GANX
Gain Therapeutics Presents Positive Interim Data from Phase 1b Clinical Study of GT-02287 at 3rd International GBA1 Meeting 2026
globenewswire.com
GANX
Form 8-K
sec.gov
GANX
Gain Therapeutics Reports Financial Results for First Quarter 2026 and Provides Corporate Update
globenewswire.com
GANX
Gain Therapeutics Announces Oral Presentation at 3rd International GBA1 Meeting 2026
globenewswire.com
GANX
Form 8-K
sec.gov
GANX
Gain Therapeutics Reports Financial Results for the Fourth Quarter and Year End 2025 and Provides Corporate Update
globenewswire.com
GANX
Gain Therapeutics to Present at the 38th Annual ROTH Conference
globenewswire.com
GANX
Form 8-K
sec.gov
GANX
Gain Therapeutics Presents Additional Clinical and Biomarker Data from Phase 1b Clinical Study of GT-02287 and Preclinical Data from Novel Chemical Series at AD/PD 2026
globenewswire.com
GANX